发明名称 |
Métodos basados en un inhibidor de HDAC 6 para el tratamiento del cáncer |
摘要 |
This invention provides methods for treating a subject afflicted with cancer, comprising concurrently administering (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide. This invention also provides methods for inducing the death of a transformed cell such as a cancer cell, comprising concurrently contacting the cell with (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide. |
申请公布号 |
ES2603750(T3) |
申请公布日期 |
2017.03.01 |
申请号 |
ES20100797676T |
申请日期 |
2010.07.02 |
申请人 |
Sloan-Kettering Institute for Cancer Research |
发明人 |
MARKS, Paul;NAMDAR, Mandana;XU, Weisheng |
分类号 |
A61K31/19;A61K31/167;A61K31/422;A61K31/704;A61K31/7048;A61K45/06;A61P35/00 |
主分类号 |
A61K31/19 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|